[
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "Medincell’s Partner Teva Pharmaceuticals Announces the New Drug Application Submission to U.S. FDA for Olanzapine Extended-Release Injectable Suspension (TEV-‘749 / mdc-TJK) for the Once-Monthly Treatment of Schizophrenia in Adults",
    "summary": "",
    "url": "https://www.medincell.com/wp-content/uploads/2025/12/MDC_Olanzapine-NDA-filing_09122025_EN_vf-2.pdf",
    "date": "2025-12-12",
    "companies_detected": [
      "MedinCell"
    ],
    "molecules_detected": [
      "olanzapine"
    ],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "Medincell Publishes its Consolidated Half-Year Financial Results (April 1st , 2025 – September 30, 2025)",
    "summary": "",
    "url": "https://www.medincell.com/wp-content/uploads/2025/12/MDC_HY-Results-EN_09122025-1.pdf",
    "date": "2025-12-12",
    "companies_detected": [
      "MedinCell"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "Videoconference and publication of half-year financial results, Tuesday, December 9, 2025",
    "summary": "",
    "url": "https://www.medincell.com/wp-content/uploads/2025/12/MDC_ConfHYR_01122025_EN.pdf",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "Medincell Management to Present at the 8th Annual Evercore Healthcare Conference and at the Piper Sandler 37th Annual Healthcare Conference",
    "summary": "",
    "url": "https://www.medincell.com/wp-content/uploads/2025/11/MDC_Evercore-Piper_Sandler_EN_27112025.pdf",
    "date": "2025-12-12",
    "companies_detected": [
      "MedinCell"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "Medincell Awarded New Grant to Fight Malaria",
    "summary": "",
    "url": "https://www.medincell.com/wp-content/uploads/2025/11/MDC_Gates-Malaria_PR_24112025_vf.pdf",
    "date": "2025-12-12",
    "companies_detected": [
      "MedinCell"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "[Replay] Jefferies Global Healthcare Conference 2025",
    "summary": "",
    "url": "https://wsw.com/webcast/jeff332/medcl/1970687",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "Medincell Appoints Dr Grace Kim, Chief Strategy Officer, U.S. Finance, to Advance into Next Stage of US Capital Growth",
    "summary": "",
    "url": "https://www.medincell.com/wp-content/uploads/2025/11/MDC_G_KIM_10112025_EN_vf.pdf",
    "date": "2025-12-12",
    "companies_detected": [
      "MedinCell"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "Medincell to Participate in the UBS Global Healthcare Conference (Palm Beach) and the Stifel Healthcare Conference (New-York)",
    "summary": "",
    "url": "https://www.medincell.com/wp-content/uploads/2025/11/MDC_UBS-STIFEL_06112025_EN_vf.pdf",
    "date": "2025-12-12",
    "companies_detected": [
      "MedinCell"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "Medincell to Join MSCI World Small Cap Index, a Leading Global Benchmark",
    "summary": "",
    "url": "https://www.medincell.com/wp-content/uploads/2025/11/MDC_MSCI-Small-Index_10112025_EN_vf.pdf",
    "date": "2025-12-12",
    "companies_detected": [
      "MedinCell"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "Medincell to Participate in the 2025 Truist Securities Biopharma Symposium (New-York)",
    "summary": "",
    "url": "https://www.medincell.com/wp-content/uploads/2025/10/MDC_Truist_22102025_EN_vf.pdf",
    "date": "2025-12-12",
    "companies_detected": [
      "MedinCell"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "UZEDY® continues strong growth; Teva setting the stage for US NDA Submission for Olanzapine LAI in Q4 2025",
    "summary": "",
    "url": "https://www.medincell.com/wp-content/uploads/2025/11/PR_MDC_Teva-earnings-Q3_2025_05112025_vf.pdf",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [
      "olanzapine"
    ],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__medincell",
    "source_type": "press_corporate",
    "title": "FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder",
    "summary": "",
    "url": "https://www.medincell.com/wp-content/uploads/2025/10/MDC_UZEDY-BDI_EN_10102025_vf.pdf",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [
      "risperidone"
    ],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "GSK spins out corporate VC fund focused on bioelectronic tech",
    "summary": "",
    "url": "https://endpoints.news/gsk-spins-out-corporate-vc-fund-focused-on-bioelectronic-tech/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Innovent’s obesity drug data in adolescents; Everest gets rights to PCSK9 inhibitor",
    "summary": "",
    "url": "https://endpoints.news/innovents-obesity-drug-data-in-adolescents-everest-gets-rights-to-pcsk9-inhibitor/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [
      "mazdutide"
    ],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Arcus, Gilead report Phase 3 TIGIT failure in upper GI cancers",
    "summary": "",
    "url": "https://endpoints.news/arcus-gilead-report-phase-3-tigit-failure-in-upper-gi-cancers/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "FDA broadens label for Amgen's Uplizna as it enters rare disease competition",
    "summary": "",
    "url": "https://endpoints.news/fda-broadens-label-for-amgens-uplizna-as-it-enters-rare-disease-competition/",
    "date": "2025-12-12",
    "companies_detected": [
      "Amgen"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Tenaya targets $60M offering after heart disease pipeline updates",
    "summary": "",
    "url": "https://endpoints.news/tenaya-targets-60m-offering-after-heart-disease-pipeline-updates/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Centessa CEO to step down; John Maraganore, Clive Meanwell find CMO for their new cardio bet",
    "summary": "",
    "url": "https://endpoints.news/centessa-ceo-to-step-down-john-maraganore-clive-meanwell-find-cmo-for-their-new-cardio-bet/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "CDC report underscores benefit of Covid-19 vaccines in kids",
    "summary": "",
    "url": "https://endpoints.news/cdc-report-underscores-benefit-of-covid-19-vaccines-in-kids/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Geron cuts one-third of staff, focusing on turning Rytelo launch around",
    "summary": "",
    "url": "https://endpoints.news/geron-cuts-one-third-of-staff-focusing-on-turning-rytelo-launch-around/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "EU forges deal over major pharma legislative changes",
    "summary": "",
    "url": "https://endpoints.news/major-eu-pharma-changes-advance-after-legislative-action/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "GSK's new antibiotic wins gonorrhea approval",
    "summary": "",
    "url": "https://endpoints.news/gsks-new-antibiotic-wins-gonorrhea-approval/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Top Trump lawyer calls on SCOTUS to reverse 'skinny' generic drug label decision",
    "summary": "",
    "url": "https://endpoints.news/top-trump-lawyer-calls-on-scotus-to-reverse-skinny-generic-drug-label-decision/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Umoja delays first readout for in vivo CAR-T therapy",
    "summary": "",
    "url": "https://endpoints.news/umoja-delays-first-readout-for-in-vivo-car-t-therapy/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Rezolute crashes as its only drug fails in Phase 3",
    "summary": "",
    "url": "https://endpoints.news/rezolute-crashes-as-its-only-drug-fails-in-phase-3/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Rhythm reports Imcivree’s key weight loss data from Phase 2 Prader-Willi trial",
    "summary": "",
    "url": "https://endpoints.news/rhythm-reports-imcivrees-key-weight-loss-data-from-phase-2-prader-willi-trial/",
    "date": "2025-12-11",
    "companies_detected": [
      "Rhythm Pharmaceuticals"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "AC Immune says early biomarker data are promising in Parkinson's, but clinical benefit remains unclear",
    "summary": "",
    "url": "https://endpoints.news/ac-immune-says-early-biomarker-data-are-promising-in-parkinsons-but-clinical-benefit-remains-unclear/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Health tech investors are getting creative with exits",
    "summary": "",
    "url": "https://endpoints.news/health-tech-investors-are-getting-creative-with-exits/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Corbus’ obesity pill posts muted weight loss data; Disco adds another €16M in seed funding",
    "summary": "",
    "url": "https://endpoints.news/corbus-obesity-pill-posts-muted-weight-loss-data-disco-adds-another-e16m-in-seed-funding/",
    "date": "2025-12-11",
    "companies_detected": [
      "AstraZeneca",
      "Nanexa"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Zealand inks deal with OTR Therapeutics as it spells out broader metabolic disease ambitions",
    "summary": "",
    "url": "https://endpoints.news/zealand-inks-deal-with-otr-therapeutics-as-it-spells-out-broader-metabolic-disease-ambitions/",
    "date": "2025-12-11",
    "companies_detected": [
      "Zealand Pharma"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO",
    "summary": "",
    "url": "https://endpoints.news/weight-loss-biotech-prolynx-gets-70m-snags-amgens-obesity-commercial-leader-as-ceo/",
    "date": "2025-12-11",
    "companies_detected": [
      "Amgen",
      "Prolynx"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Endpoints 100 survey 2025: Biotech CEOs are feeling more upbeat",
    "summary": "",
    "url": "https://endpoints.news/endpoints-100-survey-2025-biotech-ceos-are-feeling-more-upbeat/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__nanexa",
    "source_type": "press_corporate",
    "title": "Nanexa and Moderna enter into license and option agreement for the development of PharmaShell®-based products",
    "summary": "",
    "url": "https://nanexa.com/mfn_news/nanexa-and-moderna-enter-into-license-and-option-agreement-for-the-development-of-pharmashell-based-products/",
    "date": "2025-12-12",
    "companies_detected": [
      "Nanexa"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "House backs Biosecure Act aimed at Chinese companies",
    "summary": "",
    "url": "https://endpoints.news/house-backs-biosecure-act-aimed-at-chinese-companies/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__endpoints_news",
    "source_type": "press_sector",
    "title": "Lilly’s triple agonist posts strongest weight loss data yet, unusual skin side effect also reported",
    "summary": "",
    "url": "https://endpoints.news/lillys-triple-agonist-posts-strongest-weight-loss-data-yet-but-unusual-skin-side-effect-reported/",
    "date": "2025-12-11",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__nanexa",
    "source_type": "press_corporate",
    "title": "Nanexa and Moderna enter into license and option agreement for the development of PharmaShell®-based products",
    "summary": "",
    "url": "https://nanexa.com/mfn_news/nanexa-and-moderna-enter-into-license-and-option-agreement-for-the-development-of-pharmashell-based-products/",
    "date": "2025-12-12",
    "companies_detected": [
      "Nanexa"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__nanexa",
    "source_type": "press_corporate",
    "title": "Nanexa publishes interim report for January-September 2025",
    "summary": "",
    "url": "https://nanexa.com/mfn_news/nanexa-publishes-interim-report-for-january-september-2025/",
    "date": "2025-12-12",
    "companies_detected": [
      "Nanexa"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__nanexa",
    "source_type": "press_corporate",
    "title": "Nanexa publishes interim report for January-September 2025",
    "summary": "",
    "url": "https://nanexa.com/mfn_news/nanexa-publishes-interim-report-for-january-september-2025/",
    "date": "2025-12-12",
    "companies_detected": [
      "Nanexa"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__nanexa",
    "source_type": "press_corporate",
    "title": "Nanexa publishes interim report for January-June 2025",
    "summary": "",
    "url": "https://nanexa.com/mfn_news/nanexa-publishes-interim-report-for-january-june-2025/",
    "date": "2025-12-12",
    "companies_detected": [
      "Nanexa"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__nanexa",
    "source_type": "press_corporate",
    "title": "Download attachment",
    "summary": "",
    "url": "https://storage.mfn.se/ab91ff14-4c8b-4c40-85a9-996052a19950/nanexa-interim-report-january-september-2025.pdf",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__nanexa",
    "source_type": "press_corporate",
    "title": "Download attachment",
    "summary": "",
    "url": "https://storage.mfn.se/5d2c8421-0163-4592-8c9e-43752659a104/nanexa-interim-report-january-june-2025.pdf",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__nanexa",
    "source_type": "press_corporate",
    "title": "Read the presentation",
    "summary": "",
    "url": "https://nanexa.com/wp-content/uploads/2025/11/PODD-Oct-2025.pdf",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/arcus-halts-gilead-partnered-tigit-trials-biotech-reworks-rd-focus\" hreflang=\"en\">Arcus discontinues Gilead-partnered TIGIT trials due to futility</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/arcus-halts-gilead-partnered-tigit-trials-biotech-reworks-rd-focus",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/2026-outlook-biotech-poised-outperform-bear-markets-21-24-analyst-says\" hreflang=\"en\">2026 outlook: Biotech poised to outperform bear markets of ’21-24, analyst says</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/2026-outlook-biotech-poised-outperform-bear-markets-21-24-analyst-says",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/sponsored/leading-way-biotech-solutions-across-japan-and-asia-pacific-japac\" hreflang=\"en\">Leading the Way in Biotech Solutions Across Japan and Asia Pacific (JAPAC)</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/sponsored/leading-way-biotech-solutions-across-japan-and-asia-pacific-japac",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/cycle-seizes-struggling-applied-tx-picking-rare-disease-biotech-pennies\" hreflang=\"en\">Cycle seizes struggling Applied Tx, picking up rare disease biotech for pennies per share</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/cycle-seizes-struggling-applied-tx-picking-rare-disease-biotech-pennies",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/chutes-ladders-metabolic-marketing-master-maneuvers-ceo\" hreflang=\"en\">Chutes &amp; Ladders—Metabolic marketing master maneuvers to CEO</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/chutes-ladders-metabolic-marketing-master-maneuvers-ceo",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/marketing/amgen-obesity-marketing-leader-chris-boulton-takes-reins-metabolic-biotech-prolynx\" hreflang=\"en\">Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/marketing/amgen-obesity-marketing-leader-chris-boulton-takes-reins-metabolic-biotech-prolynx",
    "date": "2025-12-12",
    "companies_detected": [
      "Amgen",
      "Prolynx"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/medtech/heartbeam-swells-turning-fda-rejection-ecg-clearance\" hreflang=\"en\">HeartBeam swells on turning FDA rejection into ECG clearance</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/medtech/heartbeam-swells-turning-fda-rejection-ecg-clearance",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/medtech/fda-clears-lumos-labs-prescription-digital-therapy-treat-adhd-adults\" hreflang=\"en\">FDA clears Lumosity brain training games as a prescription app for adult ADHD</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/medtech/fda-clears-lumos-labs-prescription-digital-therapy-treat-adhd-adults",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/rezolutes-stock-plunges-87-after-hypoglycemia-drug-flunks-pivotal-phase-3-test\" hreflang=\"en\">Rezolute's stock plunges 87% after hypoglycemia drug flunks pivotal phase 3 test</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/rezolutes-stock-plunges-87-after-hypoglycemia-drug-flunks-pivotal-phase-3-test",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025\" hreflang=\"en\">Fierce Biotech Layoff Tracker 2025: Geron lays off one-third of staff; Pfizer reduces Swiss staff</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025",
    "date": "2025-12-12",
    "companies_detected": [
      "Pfizer"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/eli-lillys-obesity-triple-threat-smashes-efficacy-expectations-phase-3-proves-intolerable\" hreflang=\"en\">Lilly's obesity triple threat smashes efficacy expectations in phase 3 but proves intolerable for some</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/eli-lillys-obesity-triple-threat-smashes-efficacy-expectations-phase-3-proves-intolerable",
    "date": "2025-12-12",
    "companies_detected": [
      "Eli Lilly"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/fierce-biotech-fundraising-tracker-25\" hreflang=\"en\">Fierce Biotech Fundraising Tracker '25: Prolynx powers up with $70M series A; D3 Bio raises $108M</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/fierce-biotech-fundraising-tracker-25",
    "date": "2025-12-12",
    "companies_detected": [
      "Prolynx"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/zealand-pens-25b-cardiometabolic-collab-fresh-faced-chinese-biotech\" hreflang=\"en\">Zealand pens $2.5B oral cardiometabolic collab with fresh-faced Chinese biotech</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/zealand-pens-25b-cardiometabolic-collab-fresh-faced-chinese-biotech",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/medtech/fda-approves-its-1st-non-drug-home-treatment-depression-flow-neurosciences-brain-headset\" hreflang=\"en\">FDA approves 1st nondrug, at-home treatment for depression</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/medtech/fda-approves-its-1st-non-drug-home-treatment-depression-flow-neurosciences-brain-headset",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/moderna-taps-nanexa-improve-delivery-injectable-therapies-back-loaded-500m-pact\" hreflang=\"en\">Moderna taps Nanexa to improve delivery of injectable therapies in back-loaded $500M pact</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/moderna-taps-nanexa-improve-delivery-injectable-therapies-back-loaded-500m-pact",
    "date": "2025-12-12",
    "companies_detected": [
      "Nanexa"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/gri-touts-ipf-safety-edge-lung-function-gains-amid-cash-crunch\" hreflang=\"en\">GRI touts IPF safety edge, lung function gains amid cash crunch</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/gri-touts-ipf-safety-edge-lung-function-gains-amid-cash-crunch",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/apple-tree-partners-files-chapter-11-bankruptcy-keep-cash-flowing-portfolio-biotechs\" hreflang=\"en\">Apple Tree Partners files for bankruptcy to keep cash flowing to portfolio biotechs</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/apple-tree-partners-files-chapter-11-bankruptcy-keep-cash-flowing-portfolio-biotechs",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/sanofi-gsk-ink-preclinical-pacts-quest-new-autoimmune-and-cancer-antibodies\" hreflang=\"en\">Sanofi, GSK ink preclinical pacts in quest for new autoimmune and cancer antibodies</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/sanofi-gsk-ink-preclinical-pacts-quest-new-autoimmune-and-cancer-antibodies",
    "date": "2025-12-12",
    "companies_detected": [
      "Sanofi"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/bleekers-big-bang-formation-bio-unveils-new-subsidiary-605m-lynk-deal\" hreflang=\"en\">Bleecker's big bang: Formation Bio unveils new subsidiary with $605M Lynk deal </a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/bleekers-big-bang-formation-bio-unveils-new-subsidiary-605m-lynk-deal",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/medtech/francis-medical-gets-fda-green-light-water-vapor-ablation-therapy-treat-prostate-cancer\" hreflang=\"en\">Francis Medical gets FDA green light for water vapor ablation to treat prostate cancer</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/medtech/francis-medical-gets-fda-green-light-water-vapor-ablation-therapy-treat-prostate-cancer",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/roche-links-oral-serd-30-breast-cancer-risk-reduction-phase-3-adjuvant-trial\" hreflang=\"en\">Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/roche-links-oral-serd-30-breast-cancer-risk-reduction-phase-3-adjuvant-trial",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/chinese-biotech-helmed-az-veteran-reels-108-series-b-kras-inhibitor-phase-3-plans\" hreflang=\"en\">Chinese biotech led by AstraZeneca veteran reels in $108M for KRAS phase 3 plans</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/chinese-biotech-helmed-az-veteran-reels-108-series-b-kras-inhibitor-phase-3-plans",
    "date": "2025-12-12",
    "companies_detected": [
      "AstraZeneca"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/biotech/strong-words-big-smiles-enduring-activism-and-cautious-optimism-american-society-hematology\" hreflang=\"en\">Rainbows, pickleball and puppies: Inside the ‘enduring activism’ and ‘cautious optimism’ at ASH 2025</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/biotech/strong-words-big-smiles-enduring-activism-and-cautious-optimism-american-society-hematology",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/medtech/teleflex-inks-2b-divestment-deals-oem-urology-and-acute-care-units\" hreflang=\"en\">Teleflex inks $2B in divestment deals for OEM, urology and acute care units</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/medtech/teleflex-inks-2b-divestment-deals-oem-urology-and-acute-care-units",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercebiotech",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercebiotech.com/cro/fda-clears-1st-ai-drug-development-tool-reading-mash-images\" hreflang=\"en\">FDA qualifies 1st AI drug development tool for reading MASH images</a>",
    "summary": "",
    "url": "https://www.fiercebiotech.com/cro/fda-clears-1st-ai-drug-development-tool-reading-mash-images",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/marketing/nanovibronix-feeds-new-focus-envue-enteral-system-rebrand\" hreflang=\"en\">NanoVibronix feeds into new focus on ENvue enteral system with rebrand</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/marketing/nanovibronix-feeds-new-focus-envue-enteral-system-rebrand",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/gsk-gains-fda-expansion-antibiotic-blujepa-treatment-gonorrhea\" hreflang=\"en\">GSK gains FDA expansion for Blujepa to treat gonorrhea</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/gsk-gains-fda-expansion-antibiotic-blujepa-treatment-gonorrhea",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/amgens-uplizna-wades-crowded-myasthenia-gravis-market-after-fda-nod\" hreflang=\"en\">Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/amgens-uplizna-wades-crowded-myasthenia-gravis-market-after-fda-nod",
    "date": "2025-12-12",
    "companies_detected": [
      "Amgen"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/fierce-pharma-regulatory-tracker-second-half-2025\" hreflang=\"en\">Regulatory tracker: GSK's RSV vaccine slated for wider approval in Europe</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/fierce-pharma-regulatory-tracker-second-half-2025",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/european-legislators-reach-agreement-sweeping-pharma-policy-overhaul\" hreflang=\"en\">European legislators reach agreement on sweeping overhaul to pharma policies</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/european-legislators-reach-agreement-sweeping-pharma-policy-overhaul",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/pfizer-zealand-metabolic-disease-deals-china-1st-private-insurance-formulary\" hreflang=\"en\">Fierce Pharma Asia—Pfizer, Zealand metabolic disease deals; China's 1st private insurance formulary</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/pfizer-zealand-metabolic-disease-deals-china-1st-private-insurance-formulary",
    "date": "2025-12-12",
    "companies_detected": [
      "Pfizer",
      "Zealand Pharma"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/geron-lay-13-workforce-quest-slash-operating-costs-maximize-rytelo-launch\" hreflang=\"en\">Geron to lay off 3rd of workforce in bid to slash operating costs</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/geron-lay-13-workforce-quest-slash-operating-costs-maximize-rytelo-launch",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/marketing/abbott-extends-rally-serena-williams-lingo-cgm-push\" hreflang=\"en\">Abbott teams up with Serena Williams again in Lingo CGM push</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/marketing/abbott-extends-rally-serena-williams-lingo-cgm-push",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/marketing/amgen-obesity-marketing-leader-chris-boulton-takes-reins-metabolic-biotech-prolynx\" hreflang=\"en\">Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/marketing/amgen-obesity-marketing-leader-chris-boulton-takes-reins-metabolic-biotech-prolynx",
    "date": "2025-12-12",
    "companies_detected": [
      "Amgen",
      "Prolynx"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/pfizers-cost-cutting-drive-reaches-switzerland-where-company-plans-lay-hundreds-year-end\" hreflang=\"en\">Pfizer's cost-cutting drive reaches Switzerland, where company plans to lay off hundreds by year-end: Bloomberg</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/pfizers-cost-cutting-drive-reaches-switzerland-where-company-plans-lay-hundreds-year-end",
    "date": "2025-12-12",
    "companies_detected": [
      "Pfizer"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/ftc-claims-win-teva-moves-delist-hundreds-patents-fda-orange-book\" hreflang=\"en\">FTC claims a win as Teva moves to delist hundreds of patents from FDA Orange Book, agency says</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/ftc-claims-win-teva-moves-delist-hundreds-patents-fda-orange-book",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/manufacturing/cdmo-adare-plots-137-layoffs-philly-shortly-after-transplanting-headquarters-new\" hreflang=\"en\">CDMO Adare plots 137 layoffs in Philly shortly after transplanting headquarters from N.J.</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/manufacturing/cdmo-adare-plots-137-layoffs-philly-shortly-after-transplanting-headquarters-new",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/marketing/az-gilead-backed-program-reduced-side-effects-distress-black-breast-cancer-patients-study\" hreflang=\"en\">AZ-, Gilead-backed program reduced side effects, distress in Black breast cancer patients: study</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/marketing/az-gilead-backed-program-reduced-side-effects-distress-black-breast-cancer-patients-study",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/manufacturing/fda-awards-1st-national-priority-nod-usantibiotics-augmentin-xr-after-2-month-review\" hreflang=\"en\">FDA awards 1st national priority nod to USAntibiotics' Augmentin XR</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/manufacturing/fda-awards-1st-national-priority-nod-usantibiotics-augmentin-xr-after-2-month-review",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/uk-cuts-medicine-discount-rate-us-intervention\" hreflang=\"en\">In win for pharma, UK cuts medicine rebate rate following US intervention</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/uk-cuts-medicine-discount-rate-us-intervention",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/marketing/fda-finalizes-guidance-promotional-materials-biologics-and-biosimilars\" hreflang=\"en\">FDA finalizes guidance on promotional materials for biologics and biosimilars</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/marketing/fda-finalizes-guidance-promotional-materials-biologics-and-biosimilars",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/italian-non-profit-fondazione-telethon-lands-fda-approval-first-gene-therapy-treat-rare\" hreflang=\"en\">Italian nonprofit lands FDA approval for 1st gene therapy to treat rare genetic disease</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/italian-non-profit-fondazione-telethon-lands-fda-approval-first-gene-therapy-treat-rare",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/marketing/after-deal-spree-supreme-group-unites-agencies-form-pr-and-communications-group\" hreflang=\"en\">After deal spree, Supreme Group unites agencies to form new PR and communications group</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/marketing/after-deal-spree-supreme-group-unites-agencies-form-pr-and-communications-group",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/manufacturing/cdmos-bora-corealis-link-provide-one-stop-shop-oral-solid-dose-production-development\" hreflang=\"en\">CDMOs Bora, Corealis link up to provide one-stop shop for oral solid dose production, development</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/manufacturing/cdmos-bora-corealis-link-provide-one-stop-shop-oral-solid-dose-production-development",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/pfizer-tukysa-delays-her2-breast-cancer-progression-first-line-maintenance-therapy\" hreflang=\"en\">Pfizer's Tukysa delays HER2 breast cancer progression as 1st-line maintenance therapy</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/pfizer-tukysa-delays-her2-breast-cancer-progression-first-line-maintenance-therapy",
    "date": "2025-12-12",
    "companies_detected": [
      "Pfizer"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/marketing/genentech-uncovers-hidden-gems-latest-iteration-multiple-sclerosis-visibility-drive\" hreflang=\"en\">Genentech uncovers 'Hidden GeMS' in latest iteration of multiple sclerosis visibility drive</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/marketing/genentech-uncovers-hidden-gems-latest-iteration-multiple-sclerosis-visibility-drive",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/roll-tide-lilly-selects-alabama-site-location-6b-api-facility-0\" hreflang=\"en\">Roll Tide: Lilly selects Alabama site as location for $6B API facility</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/roll-tide-lilly-selects-alabama-site-location-6b-api-facility-0",
    "date": "2025-12-12",
    "companies_detected": [
      "Eli Lilly"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/viatris-returns-stake-biocon-biologics-815m-setting-biosimilar-market-re-entry-biocon\" hreflang=\"en\">Biocon buys out Viatris and others from biosimilar subsidiary</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/viatris-returns-stake-biocon-biologics-815m-setting-biosimilar-market-re-entry-biocon",
    "date": "2025-12-12",
    "companies_detected": [
      "Biocon"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/fda-now-has-merck-az-and-sanofi-rsv-shots-infants-its-crosshairs-reuters\" hreflang=\"en\">FDA now has Merck, AZ and Sanofi RSV shots for infants in its crosshairs: Reuters</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/fda-now-has-merck-az-and-sanofi-rsv-shots-infants-its-crosshairs-reuters",
    "date": "2025-12-12",
    "companies_detected": [
      "Sanofi"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_sector__fiercepharma",
    "source_type": "press_sector",
    "title": "<a href=\"https://www.fiercepharma.com/pharma/biosecure-legislation-makes-way-key-us-defense-bill-teeing-potential-china-biopharma\" hreflang=\"en\">Biosecure Act slips into key US defense bill, teeing up potential China biopharma constraints in '26</a>",
    "summary": "",
    "url": "https://www.fiercepharma.com/pharma/biosecure-legislation-makes-way-key-us-defense-bill-teeing-potential-china-biopharma",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__delsitech",
    "source_type": "press_corporate",
    "title": "DelSiTech Seeks an Experienced Quality Director",
    "summary": "",
    "url": "https://www.delsitech.com/delsitech-seeks-an-experienced-quality-director/",
    "date": "2025-12-12",
    "companies_detected": [
      "DelSiTech"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__delsitech",
    "source_type": "press_corporate",
    "title": "DelSiTech is Hiring a Process Engineer",
    "summary": "",
    "url": "https://www.delsitech.com/delsitech-is-hiring-a-process-engineer/",
    "date": "2025-12-12",
    "companies_detected": [
      "DelSiTech"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__delsitech",
    "source_type": "press_corporate",
    "title": "DelSiTech announces a leadership change. Carl-Åke Carlsson, CEO of DelSiTech, leaves the company and the Board nominates Martti Hedman as Interim CEO.",
    "summary": "",
    "url": "https://www.delsitech.com/delsitech-announces-a-leadership-change-carl-ake-carlsson-ceo-of-delsitech-leaves-the-company-and-the-board-nominates-martti-hedman-as-interim-ceo/",
    "date": "2025-12-12",
    "companies_detected": [
      "DelSiTech"
    ],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__delsitech",
    "source_type": "press_corporate",
    "title": "Appointment of Outi Heikkilä as Chief Operations Officer",
    "summary": "",
    "url": "https://www.delsitech.com/appointment-of-outi-heikkila-as-chief-operations-officer/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__delsitech",
    "source_type": "press_corporate",
    "title": "Partnership Opportunities in Drug Delivery 2025 Boston, October 27-28",
    "summary": "",
    "url": "https://www.delsitech.com/partnership-opportunities-in-drug-delivery-2025-boston-october-27-28/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__delsitech",
    "source_type": "press_corporate",
    "title": "World Vaccine Congress Europe 2025 Amsterdam, October 13-16",
    "summary": "",
    "url": "https://www.delsitech.com/world-vaccine-congress-europe-2025-amsterdam-october-13-16/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__delsitech",
    "source_type": "press_corporate",
    "title": "Drug Delivery and Formulation Summit 2025 Boston, September 15-16",
    "summary": "",
    "url": "https://www.delsitech.com/drug-delivery-and-formulation-summit-2025-boston-september-15-16/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__delsitech",
    "source_type": "press_corporate",
    "title": "CRS Annual Meeting & Exposition 2025 Philadelphia, July 14-18",
    "summary": "",
    "url": "https://www.delsitech.com/crs-annual-meeting-exposition-2025-philadelphia-july-14-18/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__delsitech",
    "source_type": "press_corporate",
    "title": "BIO International Convention 2025 Boston, June 16-19",
    "summary": "",
    "url": "https://www.delsitech.com/bio-international-convention-2025-boston-june-16-19/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  },
  {
    "source_key": "press_corporate__delsitech",
    "source_type": "press_corporate",
    "title": "World Vaccine Congress 2025 Washington, April 21-24",
    "summary": "",
    "url": "https://www.delsitech.com/world-vaccine-congress-2025-washington-april-21-24/",
    "date": "2025-12-12",
    "companies_detected": [],
    "molecules_detected": [],
    "technologies_detected": [],
    "indications_detected": [],
    "event_type": "other",
    "domain_relevance": []
  }
]